Preclinical evaluation of ELP‐004 in mice
Abstract This study provides a detailed understanding of the preclinical pharmacokinetics and metabolism of ELP‐004, an osteoclast inhibitor in development for the treatment of bone erosion. Current treatments for arthritis, including biological disease‐modifying antirheumatic drugs, are not well‐to...
Saved in:
Main Authors: | Jamie L. McCall (Author), Werner J. Geldenhuys (Author), Lisa J. Robinson (Author), Michelle R. Witt (Author), Peter M. Gannett (Author), Björn C. G. Söderberg (Author), Harry C. Blair (Author), Jonathan Soboloff (Author), John B. Barnett (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CONTRIBUTION OF THE ELP USE ON LEARNING TURKISH AS A FOREIGN LANGUAGE
by: Burcu Ak Şentürk, et al.
Published: (2019) -
Elp1 is required for development of visceral sensory peripheral and central circuitry
by: Zariah Tolman, et al.
Published: (2022) -
Triple selectin knockout (ELP-/-) mice fail to develop OVA-induced acute asthma phenotype
by: Banerjee Ena
Published: (2011) -
Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD
by: Yuanjing Liu, et al.
Published: (2022) -
The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection
by: C. Gay, et al.
Published: (2019)